Increased survival using delayed gamma knife radiosurgery for recurrent high-grade glioma: a feasibility study (Q44999375)

8 December 2017

title

Increased survival using delayed gamma knife radiosurgery for recurrent high-grade glioma: a feasibility study (English)

1 reference

8 December 2017

1 reference

16

Mikael Svensson

1 reference

8 December 2017

3

Inti Peredo

1 reference

8 December 2017

1

Ernest Dodoo

1 reference

8 December 2017

Beate Huffmann

2

1 reference

8 December 2017

Hanne Grinaker

4

1 reference

8 December 2017

Georges Sinclair

5

1 reference

8 December 2017

Theofilos Machinis

6

1 reference

8 December 2017

Per Oyvind Enger

7

1 reference

8 December 2017

Bente Sandvei Skeie

8

1 reference

8 December 2017

Paal-Henning Pedersen

9

1 reference

8 December 2017

Marcus Ohlsson

10

1 reference

8 December 2017

Abiel Orrego

11

1 reference

8 December 2017

Thomas Kraepelien

12

1 reference

8 December 2017

Pierre Barsoum

13

1 reference

8 December 2017

Hamza Benmakhlouf

14

1 reference

8 December 2017

Lars Herrman

15

1 reference

8 December 2017

Bodo Lippitz

17

1 reference

8 December 2017

publication date

13 June 2014

1 reference

8 December 2017

1 reference

8 December 2017

volume

82

1 reference

8 December 2017

issue

5

1 reference

8 December 2017

page(s)

e623-32

1 reference

Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Status quo--standard-of-care medical and radiation therapy for glioblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Stereotactic radiosurgery for glioblastoma: retrospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Stereotactic radiosurgery for recurrent gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

[Systematic review of stereotactic radiotherapy for high-grade gliomas].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Boost Gamma Knife radiosurgery in the treatment of primary glial tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Gamma knife surgery for glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Role of radiation therapy and radiosurgery in glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Radiosurgery for glioblastoma multiforme: the importance of selection criteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Patterns of second recurrence of malignant astrocytomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

γ knife surgery versus reoperation for recurrent glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Changing paradigms--an update on the multidisciplinary management of malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

The role of the Gamma Knife in the management of cerebral astrocytomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Bevacizumab and recurrent malignant gliomas: a European perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

Glioblastoma: patterns of recurrence and efficacy of salvage treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2014.06.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.WNEU.2014.06.011

1 reference

8 December 2017

1 reference